Pfizer, BioNTech express dedication to making safe Covid vaccines

Pfizer (PFE) and BioNTech (BNTX) said in a statement: “COVID-19 has transitioned from a pandemic to an endemic disease. Even so, COVID-19 disease still hospitalizes hundreds of thousands of Americans and is responsible for the death of thousands every year. Pfizer and BioNTech remain deeply committed to making safe and effective vaccines that help protect lives in the U.S. and around the world. The Pfizer-BioNTech COVID-19 vaccine has been reviewed by multiple regulatory authorities, including the FDA, and has met all safety and quality control guidelines…In summary, Pfizer and BioNTech remain steadfast in our dedication to vaccine safety, quality and effectiveness through constant safety monitoring and ongoing research. With 5 billion doses distributed to date globally and continued approval by regulatory agencies in 83 countries, our vaccines are among the most extensively monitored products licensed in the world-helping prevent hospitalizations and saving lives.”